Delivery Order SPE2DB22D2218-SPE2DB26FR1PD
- Not listed
- The Defense Logistics Agency awarded a $8,236.17 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials, with completion expected by October 28, 2025. This non-set-aside contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials, with a ceiling value of $37,519.00. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is set to conclude on November 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $11,867.82 delivery order to AmerisourceBergen Drug Corp for Ozempic 2 mg/dose (8 mg/3 mL) 3 mL vials on November 25, 2025, with a completion date of November 26, 2025. This competitively awarded, firm fixed-price delivery order represents a single-line pharmaceutical supply transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $14,981.54 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials, with completion targeted for September 2, 2025. This competitively awarded, firm fixed-price contract reflects no set-aside designation and is performed from AmerisourceBergen's location in Conshohocken, Pennsylvania. The delivery order falls under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials, with a ceiling value of $12,426.16 and a completion date of November 18, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $46,386.40 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be fulfilled at the vendor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $3,816.15 delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials, with completion targeted for November 3, 2025. This is a firm fixed-price delivery order issued without set-aside designation, meaning it was competitively awarded. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a $28,736.70 delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 1, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing...
- The Defense Logistics Agency awarded a $5,460.12 delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) in 3 ml vials, with an ultimate completion date of November 17, 2025. This competitively awarded, firm fixed-price contract, which is not set aside for any special program, will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award is issued under...
- The Defense Logistics Agency awarded a $33,778.76 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This is a firm fixed price, non-set-aside contract with a completion date of September 23, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB26FR1PDDelivery Order
The Defense Logistics Agency awarded a $20,894.96 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3ml vials, with an ultimate completion date of October 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under a larger Indefinite Delivery Contract (IDC) vehicle—the DLA Troop Support Medical contract SPE2DX valued at $999,999,999.00 and extending through December 2026—which serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, utilizes the SPE2DX contract to supply an extensive portfolio of pharmaceutical products and medical supplies to support Defense Health Agency operations and other federal healthcare systems worldwide. This delivery order for Ozempic, a widely-prescribed diabetes medication, exemplifies the company's role in fulfilling routine pharmaceutical supply requirements across the military medical supply chain. The contract demonstrates AmerisourceBergen's established capability to compete successfully in federal pharmaceutical procurement and deliver specialty medications on a firm fixed-price basis to support military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.9k | 10/21/25 |